For full year 2024, Royalty Pharma announced new transactions of up to approximately $2.8 billion. The announced transactions amount reflects the entire amount of capital committed for new ...
Canadian cleantech firm's solutions positioned as low-hanging fruit for multinational pharmaceutical companies looking to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback